Treatment round | Outcome | Placebo | SP/AQ | Â |
---|---|---|---|---|
Treatment 1 (September) | Received | 637 (99.8%) | 638 (99.8%) | Â |
 | Refused | 0 | 0 |  |
 | Absent | 1 (0.2%) | 1 (0.2%) |  |
Treatment 2 (October) | Received | 617 (96.7%) | 614 (96.1%) | Â |
 | Refused | 7 (1.1%) | 8 (1.3%) |  |
 | Absent | 14 (2.2%) | 17 (2.7%) |  |
Treatment 3 (November) | Received | 614 (96.2%) | 609 (95.3%) | Â |
 | Refused | 9 (1.4%) | 13 (2.0%) |  |
 | Absent | 15 (2.4%) | 17 (2.7%) |  |
Overall treatment coverage | Â | Â | p-value | |
% with 3 treatments | 604 (94.7%) | 597 (93.4%) | 0.35 | |
% with 0 treatments | 1 (0.2%) | 1 (0.2%) | 1.00 |